Featured Press Releases

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Dr. Behzad Mahdavi Has Been Appointed Executive Chairman of Biodextris to Lead Its Global Commercial Expansion

Dr. Behzad Mahdavi Has Been Appointed Executive Chairman of Biodextris to Lead Its Global Commercial Expansion

  • 04 Jun 2025

Biodextris, a leading Contract Development and Manufacturing Organization (CDMO) rooted in the...

CollPlant Expands Its rhCollagen 3D Bioprinting Portfolio Through the Launch of Ready-to-Print BioFlex

CollPlant Expands Its rhCollagen 3D Bioprinting Portfolio Through the Launch of Ready-to-Print BioFlex

Illumina

Illumina's Constellation Mapped Read technology uncovers hard-to-see genomic insights in the GeneDx pilot

Pharmaceutical Leader Nia Tatsis, Ph.D., Appointed to Odyssey Therapeutics’ Board of Directors

Pharmaceutical Leader Nia Tatsis, Ph.D., Appointed to Odyssey Therapeutics’ Board of Directors

EMS and BD expand access to GLP-1 therapies in Brazil by launching semaglutide.

EMS and BD expand access to GLP-1 therapies in Brazil by launching semaglutide.

Niagen Bioscience Launched Niagen™ Plus Liquid At-Home Injections to Support Its Telehealth Expansion

Niagen Bioscience Launched Niagen™ Plus Liquid At-Home Injections to Support Its Telehealth Expansion

  • Niagen Bioscience, Inc
  • 23 Oct 2026
Aptar Appoints Pharma Packaging Veteran Virginie Maes as President of its Pharma Business

Aptar Appoints Pharma Packaging Veteran Virginie Maes as President of its Pharma Business

  • AptarGroup, Inc.
  • 22 Oct 2026
Zai Lab Reports High Response Rates, Encouraging Durability, and a Favorable Safety Profile for Zocilurtatug Pelitecan (Zoci; Formerly ZL-1310) in First-Line Extensive-Stage Small Cell Lung Cancer

Zai Lab Reports High Response Rates, Encouraging Durability, and a Favorable Safety Profile for Zocilurtatug Pelitecan (Zoci; Formerly ZL-1310) in First-Line Extensive-Stage Small Cell Lung Cancer

  • Zai Lab Limited
  • 22 Oct 2026
Niagen Bioscience Establishes Skincare as a Permanent Tru Niagen® Category with the Launch of Dermatologist-Tested Niagen NanoCloud™ as a Core Product

Niagen Bioscience Establishes Skincare as a Permanent Tru Niagen® Category with the Launch of Dermatologist-Tested Niagen NanoCloud™ as a Core Product

  • Niagen Bioscience, Inc
  • 20 Oct 2026
BD Strengthens Peripheral Vascular Innovation Leadership with Positive AGILITY Trial Results

BD Strengthens Peripheral Vascular Innovation Leadership with Positive AGILITY Trial Results

  • BD
  • 08 Oct 2026
The meeting will focus on Nordic Pharma, Inc.’s patient data and study results on LACRIFILL® Canalicular Gel, a novel ocular surface therapy

The meeting will focus on Nordic Pharma, Inc.’s patient data and study results on LACRIFILL® Canalicular Gel, a novel ocular surface therapy

  • Nordic Pharma, Inc.
  • 08 Oct 2026

Most Popular
October   2026
M T W T F S S
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.